|
private:cbasglobal
|
12979655
|
Apr 14th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 14th, 2024 03:06AM
|
Apr 14th, 2024 03:06AM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 13th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 13th, 2024 02:01AM
|
Apr 13th, 2024 02:17PM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 12th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 12th, 2024 02:18AM
|
Apr 12th, 2024 11:21AM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 11th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 11th, 2024 04:22AM
|
Apr 11th, 2024 02:01PM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 10th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 10th, 2024 02:08AM
|
Apr 10th, 2024 08:05PM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 9th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 9th, 2024 02:39AM
|
Apr 9th, 2024 12:48PM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 8th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 8th, 2024 03:11AM
|
Apr 8th, 2024 09:45PM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 7th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 7th, 2024 02:48AM
|
Apr 7th, 2024 02:48AM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 6th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 6th, 2024 02:27AM
|
Apr 6th, 2024 02:27AM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|
|
private:cbasglobal
|
12979655
|
Apr 5th, 2024 12:00AM
|
BIOS Health Ltd
|
5.1K
|
39.00
|
Open
|
|
Apr 5th, 2024 05:07AM
|
Apr 5th, 2024 05:07AM
|
BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.
Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.
We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.
|
Open
|
artificial intelligence , data, neurotech, and neural engineering
|
Open
|
|
Cambridge
|
Cambridgeshire
|
GB
|
|
|
BIOS health
|
|
|